| Full Name | Cerena Ice |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 9346 Oak Ave, Waconia, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093428120 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Provider Name | Sunnydays Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1891914412 PECOS PAC ID: 5698900314 Enrollment ID: O20131104001388 |
News Archive
The chemical bisphenol F (found in plastics) can induce changes in a gene that is vital for neurological development. This discovery was made by researchers at the universities of Uppsala and Karlstad, Sweden.
The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumour cells, according to a study by researchers of the Group of Metabolism and Cancer at Bellvitge Biomedical Research Institute.
The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self- administered by the patient monthly.
The world's three leading public repositories for DNA and RNA sequence information have reached 100 gigabases (100,000,000,000 bases; the 'letters' of the genetic code) of sequence.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cerena Ice, 9346 Oak Ave, Waconia, MN 55387-9422 Ph: (952) 223-2506 | Cerena Ice, 9346 Oak Ave, Waconia, MN 55387-9422 Ph: (952) 223-2506 |
News Archive
The chemical bisphenol F (found in plastics) can induce changes in a gene that is vital for neurological development. This discovery was made by researchers at the universities of Uppsala and Karlstad, Sweden.
The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumour cells, according to a study by researchers of the Group of Metabolism and Cancer at Bellvitge Biomedical Research Institute.
The U.S. Food and Drug Administration today approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS). Zinbryta is a long-acting injection that is self- administered by the patient monthly.
The world's three leading public repositories for DNA and RNA sequence information have reached 100 gigabases (100,000,000,000 bases; the 'letters' of the genetic code) of sequence.
› Verified 5 days ago
Nora Carlson, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Kirstin Amber Peters, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Andrea Elizabeth Guimont, MS, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Jami Eilers, MA, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Madelin Roberts, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 | |
Christina Dalki, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9346 Oak Ave, Waconia, MN 55387 Phone: 952-223-2506 |